RUNX3 and neoplasm: Fisher’s exact test showed that the patients with tumours that had both low RUNX3 and RCAN1.4 protein expression had the higher death rate than those with tumours that had either high expression of RUNX3 or high expression of RCAN1.4 (Additional file 3: Fig. S8d).